Welcome to #1 DIGITAL HEALTH NEWS Portal

AI Cancer Tools Risk "Shortcut Learning" Rather than Detecting True Biology

New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

Artificial intelligence (AI) tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses, and cheaper testing.

Read more ...

Research Identifies Blind Spots in AI Medical Triage

ChatGPT Health, a widely used consumer artificial intelligence (AI) tool that provides health guidance directly to the public - including advice about how urgently to seek medical care - may fail to direct users appropriately to emergency care in a significant number of serious cases, according to researchers at the Icahn School of Medicine at Mount Sinai.

Read more ...

AI-Boosted Electronic Nose Detects Ovarian Cancer

Using machine learning, an electronic nose can “smell” early signs of ovarian cancer in the blood. The method is precise and, according to the LiU researchers behind the study, it could eventually be used to find many different cancers. The study is published in the scientific journal Advanced Intelligent Systems.

Read more ...

World-First Safety Guide for Public Use of AI Health Chatbots

As members of the public increasingly turn to AI with health concerns, University of Birmingham researchers are leading a global programme to build the first definitive guide for safely navigating health information on AI powered chatbots.

The initiative is announced in a correspondence published in Nature Health.

Read more ...

DMEA 2026: Stage Programme Focusing on AI, Digital Ecosystems and Smart Care Published

21 - 23 April 2026, Berlin, Germany.
Once again, the focus of the stages at DMEA 2026 will be on the digital future of healthcare. DMEA presents a congress programme that covers the entire spectrum of innovative technologies, practical applications and forward-looking concepts - from AI-supported hospital processes and smart care solutions to data-driven research. The entire DMEA 2026 congress programme can be found on the website and will be continuously updated.

Read more ...

Calls for Global Guidelines for Safer AI Use in Medicine

A world-first review led by Adelaide University researchers has found there’s a lack of clear guidelines around the early testing of AI tools in health clinics, during a process known as silent trials.

The global scoping review looked at this early phase of testing and revealed huge variations in the way the trials are being conducted and the measures used to assess the effectiveness of the tools.

Read more ...

AI-Guided Protein Design for Enhanced Intracellular Antibodies

A new artificial intelligence-driven pipeline developed in a collaborative research combines protein structure prediction, sequence design, and live-cell screening together to enable rapid conversion of antibody sequences into functional intracellular antibodies (intrabodies) that are stable within living cells. By preserving antigen-binding regions and improving structural stability, the approach overcomes major barriers encountered in intrabody development - emerging as a simpler, more cost-effective tool for diagnostics, imaging, and biomedical research.

Read more ...

AI Predicts Success of Hip Operations

In 2024, approximately 200,000 people in Germany received artificial hip joints, making this operation one of the most common orthopedic procedures in German hospitals. In most cases, such operations are performed to treat hip osteoarthritis, which is the result of wear on the cartilage surfaces of the femoral (thigh bone) head and the hip socket. In terms of mobility and freedom from pain, patients react differently to total hip replacement.

Read more ...

New AI Tool may Help Personalize Ovarian Cancer Treatment from Day One

Researchers from the University of Minnesota Medical School, in collaboration with Emory University and the Georgia Institute of Technology, have developed a new artificial intelligence (AI) biomarker tool that may help predict how ovarian cancer patients will respond to treatment at the time of diagnosis. The findings were published in the British Journal of Cancer ReportsExternal link that opens in the same window.

Read more ...

AI Model can Read and Diagnose a Brain MRI in Seconds

An AI-powered model developed at University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests.

The model detected neurological conditions with up to 97.5% accuracy and predicted how urgently a patient required treatment.

Read more ...